

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | epoxygenase P450 pathway (GO:0019373) | 8.34601955 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.56658731 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.56658731 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 7.25891152 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.25891152 |
| 6 | aromatic amino acid family catabolic process (GO:0009074) | 6.83524803 |
| 7 | omega-hydroxylase P450 pathway (GO:0097267) | 6.82888387 |
| 8 | drug metabolic process (GO:0017144) | 6.34717708 |
| 9 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.24845142 |
| 10 | tryptophan catabolic process (GO:0006569) | 6.19226483 |
| 11 | indole-containing compound catabolic process (GO:0042436) | 6.19226483 |
| 12 | indolalkylamine catabolic process (GO:0046218) | 6.19226483 |
| 13 | kynurenine metabolic process (GO:0070189) | 6.03155668 |
| 14 | bile acid biosynthetic process (GO:0006699) | 5.96302143 |
| 15 | glyoxylate metabolic process (GO:0046487) | 5.91423605 |
| 16 | tryptophan metabolic process (GO:0006568) | 5.83452788 |
| 17 | urea metabolic process (GO:0019627) | 5.67248749 |
| 18 | urea cycle (GO:0000050) | 5.67248749 |
| 19 | negative regulation of fibrinolysis (GO:0051918) | 5.53072252 |
| 20 | hormone catabolic process (GO:0042447) | 5.49798403 |
| 21 | high-density lipoprotein particle remodeling (GO:0034375) | 5.48774350 |
| 22 | alpha-linolenic acid metabolic process (GO:0036109) | 5.48048820 |
| 23 | cysteine metabolic process (GO:0006534) | 5.45882412 |
| 24 | sulfur amino acid catabolic process (GO:0000098) | 5.35483662 |
| 25 | regulation of fibrinolysis (GO:0051917) | 5.34591137 |
| 26 | complement activation, alternative pathway (GO:0006957) | 5.30333559 |
| 27 | regulation of protein activation cascade (GO:2000257) | 5.28178548 |
| 28 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.26941235 |
| 29 | protein carboxylation (GO:0018214) | 5.26941235 |
| 30 | nitrogen cycle metabolic process (GO:0071941) | 5.21600552 |
| 31 | daunorubicin metabolic process (GO:0044597) | 5.19777241 |
| 32 | polyketide metabolic process (GO:0030638) | 5.19777241 |
| 33 | doxorubicin metabolic process (GO:0044598) | 5.19777241 |
| 34 | oxidative demethylation (GO:0070989) | 5.13178854 |
| 35 | serine family amino acid catabolic process (GO:0009071) | 5.12229895 |
| 36 | phenylpropanoid metabolic process (GO:0009698) | 5.10204907 |
| 37 | bile acid metabolic process (GO:0008206) | 5.06456651 |
| 38 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.97860692 |
| 39 | aromatic amino acid family metabolic process (GO:0009072) | 4.97829434 |
| 40 | homocysteine metabolic process (GO:0050667) | 4.94645968 |
| 41 | regulation of complement activation (GO:0030449) | 4.94057314 |
| 42 | reverse cholesterol transport (GO:0043691) | 4.82207293 |
| 43 | regulation of cholesterol esterification (GO:0010872) | 4.79584823 |
| 44 | lysine catabolic process (GO:0006554) | 4.79578655 |
| 45 | lysine metabolic process (GO:0006553) | 4.79578655 |
| 46 | tyrosine metabolic process (GO:0006570) | 4.73436709 |
| 47 | protein-lipid complex remodeling (GO:0034368) | 4.72487977 |
| 48 | macromolecular complex remodeling (GO:0034367) | 4.72487977 |
| 49 | plasma lipoprotein particle remodeling (GO:0034369) | 4.72487977 |
| 50 | amino-acid betaine metabolic process (GO:0006577) | 4.66094638 |
| 51 | alpha-amino acid catabolic process (GO:1901606) | 4.64632072 |
| 52 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.63898000 |
| 53 | aminoglycoside antibiotic metabolic process (GO:0030647) | 4.59601558 |
| 54 | acylglycerol homeostasis (GO:0055090) | 4.59335656 |
| 55 | triglyceride homeostasis (GO:0070328) | 4.59335656 |
| 56 | phospholipid efflux (GO:0033700) | 4.56609454 |
| 57 | ethanol metabolic process (GO:0006067) | 4.54294725 |
| 58 | negative regulation of sterol transport (GO:0032372) | 4.52874956 |
| 59 | negative regulation of cholesterol transport (GO:0032375) | 4.52874956 |
| 60 | alkaloid metabolic process (GO:0009820) | 4.50387630 |
| 61 | cellular ketone body metabolic process (GO:0046950) | 4.50042427 |
| 62 | flavonoid metabolic process (GO:0009812) | 4.45042637 |
| 63 | intestinal cholesterol absorption (GO:0030299) | 4.44943690 |
| 64 | glycine metabolic process (GO:0006544) | 4.40527307 |
| 65 | indolalkylamine metabolic process (GO:0006586) | 4.39441142 |
| 66 | bile acid and bile salt transport (GO:0015721) | 4.38495077 |
| 67 | plasma lipoprotein particle clearance (GO:0034381) | 4.35662884 |
| 68 | coenzyme catabolic process (GO:0009109) | 4.32960001 |
| 69 | * regulation of triglyceride catabolic process (GO:0010896) | 4.30590753 |
| 70 | negative regulation of hemostasis (GO:1900047) | 4.30170598 |
| 71 | negative regulation of blood coagulation (GO:0030195) | 4.30170598 |
| 72 | cellular amino acid catabolic process (GO:0009063) | 4.29416463 |
| 73 | cellular biogenic amine catabolic process (GO:0042402) | 4.29178008 |
| 74 | amine catabolic process (GO:0009310) | 4.29178008 |
| 75 | cellular glucuronidation (GO:0052695) | 4.28379840 |
| 76 | serine family amino acid metabolic process (GO:0009069) | 4.25846124 |
| 77 | glutamate metabolic process (GO:0006536) | 4.24706917 |
| 78 | imidazole-containing compound metabolic process (GO:0052803) | 4.24213379 |
| 79 | cholesterol efflux (GO:0033344) | 4.20069270 |
| 80 | primary alcohol catabolic process (GO:0034310) | 4.18260122 |
| 81 | benzene-containing compound metabolic process (GO:0042537) | 4.15239519 |
| 82 | cellular modified amino acid catabolic process (GO:0042219) | 4.13276347 |
| 83 | ethanol oxidation (GO:0006069) | 4.10696579 |
| 84 | acute-phase response (GO:0006953) | 4.09744366 |
| 85 | serine family amino acid biosynthetic process (GO:0009070) | 4.08938516 |
| 86 | drug catabolic process (GO:0042737) | 4.08914290 |
| 87 | heme transport (GO:0015886) | 4.07155055 |
| 88 | plasma lipoprotein particle assembly (GO:0034377) | 4.03111998 |
| 89 | aldehyde catabolic process (GO:0046185) | 4.02949668 |
| 90 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.02018022 |
| 91 | arginine metabolic process (GO:0006525) | 4.00549837 |
| 92 | fibrinolysis (GO:0042730) | 3.96703403 |
| 93 | negative regulation of coagulation (GO:0050819) | 3.94887302 |
| 94 | regulation of plasminogen activation (GO:0010755) | 3.94449925 |
| 95 | negative regulation of wound healing (GO:0061045) | 3.93103670 |
| 96 | low-density lipoprotein particle remodeling (GO:0034374) | 3.91127447 |
| 97 | ketone body metabolic process (GO:1902224) | 3.89557020 |
| 98 | intestinal absorption (GO:0050892) | 3.88823123 |
| 99 | negative regulation of protein activation cascade (GO:2000258) | 3.87425052 |
| 100 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.86095453 |
| 101 | uronic acid metabolic process (GO:0006063) | 3.82327160 |
| 102 | glucuronate metabolic process (GO:0019585) | 3.82327160 |
| 103 | blood coagulation, intrinsic pathway (GO:0007597) | 3.81852788 |
| 104 | short-chain fatty acid metabolic process (GO:0046459) | 3.80272452 |
| 105 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.78794813 |
| 106 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.78794813 |
| 107 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.78497487 |
| 108 | carboxylic acid catabolic process (GO:0046395) | 3.77431879 |
| 109 | organic acid catabolic process (GO:0016054) | 3.77431879 |
| 110 | acetyl-CoA metabolic process (GO:0006084) | 3.76577435 |
| 111 | cofactor catabolic process (GO:0051187) | 3.76123885 |
| 112 | cholesterol homeostasis (GO:0042632) | 3.75995569 |
| 113 | phospholipid homeostasis (GO:0055091) | 3.75598269 |
| 114 | regulation of humoral immune response (GO:0002920) | 3.74841032 |
| 115 | regulation of bile acid biosynthetic process (GO:0070857) | 3.72395103 |
| 116 | angiotensin maturation (GO:0002003) | 3.70639933 |
| 117 | xenobiotic metabolic process (GO:0006805) | 3.70607252 |
| 118 | negative regulation of lipase activity (GO:0060192) | 3.70488775 |
| 119 | sterol homeostasis (GO:0055092) | 3.70451879 |
| 120 | cytolysis (GO:0019835) | 3.69322154 |
| 121 | complement activation, classical pathway (GO:0006958) | 3.68846680 |
| 122 | complement activation (GO:0006956) | 3.66642559 |
| 123 | protein activation cascade (GO:0072376) | 3.66094612 |
| 124 | protein-lipid complex assembly (GO:0065005) | 3.61020651 |
| 125 | plasma lipoprotein particle organization (GO:0071827) | 3.60647669 |
| 126 | regulation of cholesterol homeostasis (GO:2000188) | 3.58388636 |
| 127 | exogenous drug catabolic process (GO:0042738) | 3.58213820 |
| 128 | drug transmembrane transport (GO:0006855) | 3.57680269 |
| 129 | urate metabolic process (GO:0046415) | 3.56955943 |
| 130 | steroid catabolic process (GO:0006706) | 3.56612871 |
| 131 | S-adenosylmethionine metabolic process (GO:0046500) | 3.55095305 |
| 132 | drug transport (GO:0015893) | 3.44259653 |
| 133 | NADH metabolic process (GO:0006734) | 3.43852606 |
| 134 | positive regulation of blood coagulation (GO:0030194) | 3.36435345 |
| 135 | positive regulation of hemostasis (GO:1900048) | 3.36435345 |
| 136 | glycoside metabolic process (GO:0016137) | 3.35636605 |
| 137 | fructose metabolic process (GO:0006000) | 3.34804768 |
| 138 | negative regulation of complement activation (GO:0045916) | 3.31843613 |
| 139 | lipoprotein metabolic process (GO:0042157) | 3.26856632 |
| 140 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.26736557 |
| 141 | lipoprotein transport (GO:0042953) | 3.26087781 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.34382044 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.18757128 |
| 3 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.01931352 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.47567409 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.19349123 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.05981505 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.85412147 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.00012342 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.96875046 |
| 10 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.18280252 |
| 11 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.13717356 |
| 12 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.08262932 |
| 13 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.9514252 |
| 14 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.96298546 |
| 15 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.60407600 |
| 16 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.51389980 |
| 17 | GATA1_22025678_ChIP-Seq_K562_Human | 1.50240448 |
| 18 | * HTT_18923047_ChIP-ChIP_STHdh_Human | 1.46674244 |
| 19 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.42306753 |
| 20 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.41017387 |
| 21 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.30205096 |
| 22 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.27371889 |
| 23 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.26751966 |
| 24 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.19055900 |
| 25 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.13459322 |
| 26 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.11929857 |
| 27 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.08085367 |
| 28 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.02625269 |
| 29 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.02347282 |
| 30 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.02087491 |
| 31 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.01972289 |
| 32 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.99519121 |
| 33 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.99003600 |
| 34 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.98149101 |
| 35 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.97225391 |
| 36 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.94960847 |
| 37 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.92242174 |
| 38 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.90386596 |
| 39 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.89801003 |
| 40 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.89421909 |
| 41 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.85276645 |
| 42 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.85208361 |
| 43 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.83834172 |
| 44 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.83709255 |
| 45 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.81256941 |
| 46 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.81166188 |
| 47 | NFYA_21822215_ChIP-Seq_K562_Human | 0.80289340 |
| 48 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.79932619 |
| 49 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.79799005 |
| 50 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.78512496 |
| 51 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.77796099 |
| 52 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.76509188 |
| 53 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.75781053 |
| 54 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.75608516 |
| 55 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.75513403 |
| 56 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.74865365 |
| 57 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.72236410 |
| 58 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.71800622 |
| 59 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.71734977 |
| 60 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.71621100 |
| 61 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.70358857 |
| 62 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.70088186 |
| 63 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.70011781 |
| 64 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.69763476 |
| 65 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.69202985 |
| 66 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.68618061 |
| 67 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.66973706 |
| 68 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.66973706 |
| 69 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.66389476 |
| 70 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.64711544 |
| 71 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.64444799 |
| 72 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.64192938 |
| 73 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.64173316 |
| 74 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.63612176 |
| 75 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.63283127 |
| 76 | SA1_27219007_Chip-Seq_Bcells_Human | 0.63201089 |
| 77 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.63035487 |
| 78 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.61689673 |
| 79 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.61593800 |
| 80 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.61411005 |
| 81 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.61326007 |
| 82 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.60480926 |
| 83 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.59025057 |
| 84 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.58730450 |
| 85 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.58685986 |
| 86 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.58291656 |
| 87 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.57633615 |
| 88 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.57505279 |
| 89 | AR_20517297_ChIP-Seq_VCAP_Human | 0.56501376 |
| 90 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.55110481 |
| 91 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.54984154 |
| 92 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.53969400 |
| 93 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.53425550 |
| 94 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.52957854 |
| 95 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.52728522 |
| 96 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.51463786 |
| 97 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.51178389 |
| 98 | CBP_21632823_ChIP-Seq_H3396_Human | 0.51045739 |
| 99 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.50629256 |
| 100 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.50392488 |
| 101 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.50258535 |
| 102 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.48983819 |
| 103 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.48685838 |
| 104 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.48317630 |
| 105 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.48298218 |
| 106 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.47035302 |
| 107 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.46625450 |
| 108 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.46052941 |
| 109 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.45182658 |
| 110 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.44784430 |
| 111 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.44397870 |
| 112 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.44042059 |
| 113 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.43744421 |
| 114 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.42631154 |
| 115 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.40382753 |
| 116 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.40378499 |
| 117 | GATA2_19941826_ChIP-Seq_K562_Human | 0.39663385 |
| 118 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.38952439 |
| 119 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.38950107 |
| 120 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.38706364 |
| 121 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.38334238 |
| 122 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.38269146 |
| 123 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.37897286 |
| 124 | GATA1_19941826_ChIP-Seq_K562_Human | 0.37685550 |
| 125 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.36822615 |
| 126 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.36574416 |
| 127 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.35719209 |
| 128 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.35304341 |
| 129 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.34828927 |
| 130 | * CDX2_22108803_ChIP-Seq_LS180_Human | 0.34674943 |
| 131 | SOX3_22085726_ChIP-Seq_MUSCLE_Mouse | 0.34189753 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.24047085 |
| 2 | MP0005360_urolithiasis | 7.74407708 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.42813912 |
| 4 | MP0005365_abnormal_bile_salt | 6.11566147 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.04926379 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.21024124 |
| 7 | MP0003252_abnormal_bile_duct | 3.96366070 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.52469243 |
| 9 | MP0009840_abnormal_foam_cell | 3.14567216 |
| 10 | MP0005083_abnormal_biliary_tract | 2.97361166 |
| 11 | MP0003195_calcinosis | 2.87065558 |
| 12 | MP0005332_abnormal_amino_acid | 2.84076110 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.65409498 |
| 14 | MP0004019_abnormal_vitamin_homeostasis | 2.33395866 |
| 15 | MP0003191_abnormal_cellular_cholesterol | 2.23380793 |
| 16 | MP0000609_abnormal_liver_physiology | 2.11516495 |
| 17 | MP0002138_abnormal_hepatobiliary_system | 2.07246114 |
| 18 | MP0002118_abnormal_lipid_homeostasis | 2.05795384 |
| 19 | MP0003868_abnormal_feces_composition | 1.89234766 |
| 20 | MP0005319_abnormal_enzyme/_coenzyme | 1.81355641 |
| 21 | MP0001764_abnormal_homeostasis | 1.71035451 |
| 22 | MP0009697_abnormal_copulation | 1.64844173 |
| 23 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.57941038 |
| 24 | MP0003011_delayed_dark_adaptation | 1.51055190 |
| 25 | MP0005451_abnormal_body_composition | 1.46902136 |
| 26 | MP0009643_abnormal_urine_homeostasis | 1.34750864 |
| 27 | MP0003183_abnormal_peptide_metabolism | 1.31595235 |
| 28 | MP0003186_abnormal_redox_activity | 1.30853069 |
| 29 | MP0003656_abnormal_erythrocyte_physiolo | 1.22655571 |
| 30 | MP0000598_abnormal_liver_morphology | 1.14431092 |
| 31 | MP0003705_abnormal_hypodermis_morpholog | 1.13632014 |
| 32 | MP0005647_abnormal_sex_gland | 1.10712717 |
| 33 | MP0002254_reproductive_system_inflammat | 1.09111459 |
| 34 | MP0005636_abnormal_mineral_homeostasis | 1.03557315 |
| 35 | MP0009764_decreased_sensitivity_to | 1.03356270 |
| 36 | MP0000604_amyloidosis | 1.00651348 |
| 37 | MP0009763_increased_sensitivity_to | 0.98184603 |
| 38 | MP0010368_abnormal_lymphatic_system | 0.92415754 |
| 39 | MP0005408_hypopigmentation | 0.89959726 |
| 40 | MP0004147_increased_porphyrin_level | 0.88438610 |
| 41 | MP0008469_abnormal_protein_level | 0.87460644 |
| 42 | MP0009642_abnormal_blood_homeostasis | 0.86519947 |
| 43 | MP0006036_abnormal_mitochondrial_physio | 0.84935209 |
| 44 | MP0005084_abnormal_gallbladder_morpholo | 0.84385997 |
| 45 | MP0003879_abnormal_hair_cell | 0.82372728 |
| 46 | MP0005376_homeostasis/metabolism_phenot | 0.78835497 |
| 47 | MP0002876_abnormal_thyroid_physiology | 0.77487989 |
| 48 | MP0009765_abnormal_xenobiotic_induced | 0.77224529 |
| 49 | MP0005220_abnormal_exocrine_pancreas | 0.74787223 |
| 50 | MP0002078_abnormal_glucose_homeostasis | 0.74728550 |
| 51 | MP0005670_abnormal_white_adipose | 0.72961016 |
| 52 | MP0010155_abnormal_intestine_physiology | 0.69230792 |
| 53 | MP0001756_abnormal_urination | 0.68536926 |
| 54 | MP0002971_abnormal_brown_adipose | 0.68043651 |
| 55 | MP0005535_abnormal_body_temperature | 0.67140192 |
| 56 | MP0009053_abnormal_anal_canal | 0.66207987 |
| 57 | MP0005334_abnormal_fat_pad | 0.64560826 |
| 58 | MP0005266_abnormal_metabolism | 0.63287590 |
| 59 | MP0004130_abnormal_muscle_cell | 0.62331860 |
| 60 | MP0001661_extended_life_span | 0.61419463 |
| 61 | MP0003690_abnormal_glial_cell | 0.59135182 |
| 62 | MP0005058_abnormal_lysosome_morphology | 0.58295897 |
| 63 | MP0006035_abnormal_mitochondrial_morpho | 0.57856986 |
| 64 | MP0003329_amyloid_beta_deposits | 0.56143405 |
| 65 | MP0000639_abnormal_adrenal_gland | 0.55989823 |
| 66 | MP0002796_impaired_skin_barrier | 0.55538975 |
| 67 | MP0005187_abnormal_penis_morphology | 0.55250778 |
| 68 | MP0002136_abnormal_kidney_physiology | 0.54708577 |
| 69 | MP0004381_abnormal_hair_follicle | 0.52609130 |
| 70 | MP0003718_maternal_effect | 0.51728553 |
| 71 | MP0005448_abnormal_energy_balance | 0.51412971 |
| 72 | MP0002928_abnormal_bile_duct | 0.50359824 |
| 73 | MP0010386_abnormal_urinary_bladder | 0.50302106 |
| 74 | MP0005395_other_phenotype | 0.50040726 |
| 75 | MP0001915_intracranial_hemorrhage | 0.49488503 |
| 76 | MP0003638_abnormal_response/metabolism_ | 0.47569467 |
| 77 | MP0005464_abnormal_platelet_physiology | 0.45938199 |
| 78 | MP0002822_catalepsy | 0.45390510 |
| 79 | MP0009785_altered_susceptibility_to | 0.45260240 |
| 80 | MP0000579_abnormal_nail_morphology | 0.43897206 |
| 81 | MP0005409_darkened_coat_color | 0.43798851 |
| 82 | MP0003724_increased_susceptibility_to | 0.43355873 |
| 83 | MP0008873_increased_physiological_sensi | 0.42659542 |
| 84 | MP0000538_abnormal_urinary_bladder | 0.42534707 |
| 85 | MP0008874_decreased_physiological_sensi | 0.41297516 |
| 86 | MP0004782_abnormal_surfactant_physiolog | 0.41275682 |
| 87 | MP0008872_abnormal_physiological_respon | 0.40978524 |
| 88 | MP0003953_abnormal_hormone_level | 0.39917542 |
| 89 | MP0005166_decreased_susceptibility_to | 0.38192990 |
| 90 | MP0009384_cardiac_valve_regurgitation | 0.37471891 |
| 91 | MP0005023_abnormal_wound_healing | 0.37000708 |
| 92 | MP0003959_abnormal_lean_body | 0.36865155 |
| 93 | MP0002837_dystrophic_cardiac_calcinosis | 0.36786802 |
| 94 | MP0005666_abnormal_adipose_tissue | 0.36684893 |
| 95 | MP0003436_decreased_susceptibility_to | 0.36610308 |
| 96 | MP0003075_altered_response_to | 0.36305085 |
| 97 | MP0005164_abnormal_response_to | 0.36220541 |
| 98 | MP0004043_abnormal_pH_regulation | 0.35407910 |
| 99 | MP0000230_abnormal_systemic_arterial | 0.34983656 |
| 100 | MP0009672_abnormal_birth_weight | 0.33637127 |
| 101 | MP0000566_synostosis | 0.32431382 |
| 102 | MP0005248_abnormal_Harderian_gland | 0.32374947 |
| 103 | MP0008004_abnormal_stomach_pH | 0.31380752 |
| 104 | MP0002060_abnormal_skin_morphology | 0.30776087 |
| 105 | MP0001243_abnormal_dermal_layer | 0.30617371 |
| 106 | MP0010234_abnormal_vibrissa_follicle | 0.30569704 |
| 107 | MP0002168_other_aberrant_phenotype | 0.30171575 |
| 108 | MP0001664_abnormal_digestion | 0.29967344 |
| 109 | MP0009115_abnormal_fat_cell | 0.29425586 |
| 110 | MP0000462_abnormal_digestive_system | 0.28482869 |
| 111 | MP0004264_abnormal_extraembryonic_tissu | 0.28428064 |
| 112 | MP0001765_abnormal_ion_homeostasis | 0.28232182 |
| 113 | MP0001845_abnormal_inflammatory_respons | 0.28211290 |
| 114 | MP0002132_abnormal_respiratory_system | 0.27929633 |
| 115 | MP0009379_abnormal_foot_pigmentation | 0.27505817 |
| 116 | MP0001881_abnormal_mammary_gland | 0.27417795 |
| 117 | MP0004883_abnormal_blood_vessel | 0.26965129 |
| 118 | MP0000249_abnormal_blood_vessel | 0.26819083 |
| 119 | MP0001853_heart_inflammation | 0.26683631 |
| 120 | MP0002089_abnormal_postnatal_growth/wei | 0.26676334 |
| 121 | MP0000477_abnormal_intestine_morphology | 0.25848411 |
| 122 | MP0001663_abnormal_digestive_system | 0.24299544 |
| 123 | MP0003300_gastrointestinal_ulcer | 0.23596479 |
| 124 | MP0002970_abnormal_white_adipose | 0.23355439 |
| 125 | MP0002249_abnormal_larynx_morphology | 0.22892937 |
| 126 | MP0000467_abnormal_esophagus_morphology | 0.21481984 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 7.31685964 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.29975960 |
| 3 | Deep venous thrombosis (HP:0002625) | 7.24916631 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.54008378 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 6.43489436 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 6.35269503 |
| 7 | Xanthomatosis (HP:0000991) | 6.25959751 |
| 8 | Complement deficiency (HP:0004431) | 5.31446574 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 5.28353177 |
| 10 | Hypolipoproteinemia (HP:0010981) | 4.74401673 |
| 11 | Joint hemorrhage (HP:0005261) | 4.69834747 |
| 12 | Hyperammonemia (HP:0001987) | 4.66024137 |
| 13 | Epidermoid cyst (HP:0200040) | 4.51657248 |
| 14 | Hyperglycinemia (HP:0002154) | 4.49462014 |
| 15 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.37461402 |
| 16 | Abnormality of the common coagulation pathway (HP:0010990) | 4.35387609 |
| 17 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.31538609 |
| 18 | Ketosis (HP:0001946) | 4.31337503 |
| 19 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.21662369 |
| 20 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.19178143 |
| 21 | Fat malabsorption (HP:0002630) | 4.16776150 |
| 22 | Abnormality of methionine metabolism (HP:0010901) | 4.16098892 |
| 23 | Hyperglycinuria (HP:0003108) | 4.10999062 |
| 24 | Hypoalphalipoproteinemia (HP:0003233) | 4.09664663 |
| 25 | Abnormality of glycine metabolism (HP:0010895) | 4.06619894 |
| 26 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.06619894 |
| 27 | Hypoglycemic coma (HP:0001325) | 3.88462732 |
| 28 | Abnormality of complement system (HP:0005339) | 3.87701212 |
| 29 | Conjugated hyperbilirubinemia (HP:0002908) | 3.79116821 |
| 30 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.77870063 |
| 31 | Abnormality of the intrinsic pathway (HP:0010989) | 3.68457514 |
| 32 | Hypercholesterolemia (HP:0003124) | 3.52250136 |
| 33 | Nephritis (HP:0000123) | 3.50428553 |
| 34 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.42945737 |
| 35 | Hyperbilirubinemia (HP:0002904) | 3.35921258 |
| 36 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.35205075 |
| 37 | Abnormality of nucleobase metabolism (HP:0010932) | 3.15541795 |
| 38 | Abnormality of serum amino acid levels (HP:0003112) | 3.13976523 |
| 39 | Ketoacidosis (HP:0001993) | 3.13531968 |
| 40 | Delayed CNS myelination (HP:0002188) | 3.10851719 |
| 41 | Steatorrhea (HP:0002570) | 3.10589027 |
| 42 | Hepatocellular carcinoma (HP:0001402) | 3.02066528 |
| 43 | Osteomalacia (HP:0002749) | 2.96771589 |
| 44 | Abnormality of vitamin metabolism (HP:0100508) | 2.95865331 |
| 45 | Spontaneous abortion (HP:0005268) | 2.90372747 |
| 46 | Hypochromic microcytic anemia (HP:0004840) | 2.90029879 |
| 47 | Reduced antithrombin III activity (HP:0001976) | 2.86995853 |
| 48 | Metabolic acidosis (HP:0001942) | 2.85250329 |
| 49 | Abnormality of purine metabolism (HP:0004352) | 2.84377662 |
| 50 | Myocardial infarction (HP:0001658) | 2.82177932 |
| 51 | Gout (HP:0001997) | 2.72965422 |
| 52 | Skin nodule (HP:0200036) | 2.71250243 |
| 53 | Systemic lupus erythematosus (HP:0002725) | 2.69314786 |
| 54 | Lethargy (HP:0001254) | 2.69010511 |
| 55 | Acanthocytosis (HP:0001927) | 2.68477729 |
| 56 | Dicarboxylic aciduria (HP:0003215) | 2.67164827 |
| 57 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.67164827 |
| 58 | Vascular calcification (HP:0004934) | 2.62823759 |
| 59 | Hyperphosphaturia (HP:0003109) | 2.56350823 |
| 60 | Cerebral edema (HP:0002181) | 2.51268324 |
| 61 | Spastic diplegia (HP:0001264) | 2.44810905 |
| 62 | Abnormal gallbladder morphology (HP:0012437) | 2.44203922 |
| 63 | Hypoglycemic seizures (HP:0002173) | 2.43600472 |
| 64 | Cholelithiasis (HP:0001081) | 2.37596540 |
| 65 | Irritability (HP:0000737) | 2.37359047 |
| 66 | Glomerulonephritis (HP:0000099) | 2.36797932 |
| 67 | Widely patent fontanelles and sutures (HP:0004492) | 2.36488853 |
| 68 | Neonatal onset (HP:0003623) | 2.36178719 |
| 69 | Malnutrition (HP:0004395) | 2.34467336 |
| 70 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.33989530 |
| 71 | Cardiovascular calcification (HP:0011915) | 2.32370014 |
| 72 | Abnormal urine phosphate concentration (HP:0012599) | 2.31464403 |
| 73 | Elevated alkaline phosphatase (HP:0003155) | 2.30692313 |
| 74 | Cholecystitis (HP:0001082) | 2.30377771 |
| 75 | Abnormal gallbladder physiology (HP:0012438) | 2.30377771 |
| 76 | Mitral stenosis (HP:0001718) | 2.28399143 |
| 77 | Facial shape deformation (HP:0011334) | 2.27718310 |
| 78 | Potter facies (HP:0002009) | 2.27718310 |
| 79 | Generalized aminoaciduria (HP:0002909) | 2.26469676 |
| 80 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.21401925 |
| 81 | Amyloidosis (HP:0011034) | 2.20244469 |
| 82 | Pancreatitis (HP:0001733) | 2.18210690 |
| 83 | Enlarged kidneys (HP:0000105) | 2.15990009 |
| 84 | Cerebral palsy (HP:0100021) | 2.15861959 |
| 85 | Vomiting (HP:0002013) | 2.15710152 |
| 86 | Esophageal varix (HP:0002040) | 2.14085883 |
| 87 | Sensorimotor neuropathy (HP:0007141) | 2.13708670 |
| 88 | Gingival bleeding (HP:0000225) | 2.12529331 |
| 89 | Brushfield spots (HP:0001088) | 2.11891391 |
| 90 | Late onset (HP:0003584) | 2.10942775 |
| 91 | Hypophosphatemia (HP:0002148) | 2.10806829 |
| 92 | Menorrhagia (HP:0000132) | 2.09108738 |
| 93 | Alkalosis (HP:0001948) | 2.08570820 |
| 94 | Rickets (HP:0002748) | 2.07637124 |
| 95 | Poikilocytosis (HP:0004447) | 2.03900123 |
| 96 | Thrombophlebitis (HP:0004418) | 2.01889495 |
| 97 | Abnormality of the gallbladder (HP:0005264) | 1.99463909 |
| 98 | Hydroxyprolinuria (HP:0003080) | 1.98641410 |
| 99 | Abnormality of proline metabolism (HP:0010907) | 1.98641410 |
| 100 | Abnormality of the Achilles tendon (HP:0005109) | 1.98170558 |
| 101 | Opisthotonus (HP:0002179) | 1.97195284 |
| 102 | Proximal tubulopathy (HP:0000114) | 1.97118119 |
| 103 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.95510214 |
| 104 | Nephrolithiasis (HP:0000787) | 1.93914079 |
| 105 | Abnormal cartilage morphology (HP:0002763) | 1.93749189 |
| 106 | Purpura (HP:0000979) | 1.91796577 |
| 107 | Renal cortical cysts (HP:0000803) | 1.90932892 |
| 108 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.90804490 |
| 109 | Glycosuria (HP:0003076) | 1.90803468 |
| 110 | Abnormality of urine glucose concentration (HP:0011016) | 1.90803468 |
| 111 | Increased purine levels (HP:0004368) | 1.90763169 |
| 112 | Hyperuricemia (HP:0002149) | 1.90763169 |
| 113 | Hemorrhage of the eye (HP:0011885) | 1.88830971 |
| 114 | Hypophosphatemic rickets (HP:0004912) | 1.88071122 |
| 115 | Pulmonary embolism (HP:0002204) | 1.87434159 |
| 116 | Nausea (HP:0002018) | 1.86054751 |
| 117 | Abnormality of iron homeostasis (HP:0011031) | 1.85870200 |
| 118 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.85510556 |
| 119 | Confusion (HP:0001289) | 1.81770387 |
| 120 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.78673161 |
| 121 | Arthropathy (HP:0003040) | 1.74797807 |
| 122 | Pigmentary retinal degeneration (HP:0001146) | 1.73311384 |
| 123 | Joint swelling (HP:0001386) | 1.73307883 |
| 124 | Paraparesis (HP:0002385) | 1.72954373 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.24112519 |
| 2 | ACVR1B | 5.00185639 |
| 3 | FGFR4 | 4.43605365 |
| 4 | SIK1 | 4.23741772 |
| 5 | ERN1 | 4.04426625 |
| 6 | PDK2 | 3.33055523 |
| 7 | ERBB4 | 3.11141491 |
| 8 | TAOK3 | 3.04817668 |
| 9 | INSRR | 2.93089609 |
| 10 | EPHA2 | 2.84296339 |
| 11 | MST1R | 2.69230777 |
| 12 | PRPF4B | 2.53927808 |
| 13 | MAP3K12 | 2.37211390 |
| 14 | MAP2K4 | 2.18909057 |
| 15 | PKN2 | 2.11885447 |
| 16 | MAPK11 | 2.05131279 |
| 17 | PRKG2 | 1.88118469 |
| 18 | PIK3CG | 1.83475264 |
| 19 | FLT3 | 1.83445965 |
| 20 | FRK | 1.83198712 |
| 21 | LATS1 | 1.79827828 |
| 22 | TYK2 | 1.65912816 |
| 23 | ABL2 | 1.52797959 |
| 24 | DAPK2 | 1.48118587 |
| 25 | NEK9 | 1.46889265 |
| 26 | PTK6 | 1.46863599 |
| 27 | MYLK | 1.46574665 |
| 28 | AKT3 | 1.46199808 |
| 29 | TRIB3 | 1.45048546 |
| 30 | FGFR2 | 1.31541672 |
| 31 | MAP3K7 | 1.27084643 |
| 32 | STK38L | 1.26492244 |
| 33 | JAK2 | 1.22490814 |
| 34 | PRKAA2 | 1.18185044 |
| 35 | KDR | 1.16723551 |
| 36 | TESK2 | 1.13741675 |
| 37 | GRK6 | 1.13372833 |
| 38 | ERBB2 | 1.12168340 |
| 39 | PINK1 | 1.08500719 |
| 40 | TBK1 | 1.01892094 |
| 41 | SCYL2 | 1.01043816 |
| 42 | NLK | 0.99810927 |
| 43 | MET | 0.97455479 |
| 44 | MAPK4 | 0.96666848 |
| 45 | MAP3K14 | 0.96464289 |
| 46 | MAP3K3 | 0.96375806 |
| 47 | MAP3K1 | 0.95136314 |
| 48 | MAP3K10 | 0.93629700 |
| 49 | MAP2K3 | 0.93492462 |
| 50 | MAPK15 | 0.91852206 |
| 51 | JAK1 | 0.91392552 |
| 52 | PRKCZ | 0.90720222 |
| 53 | STK39 | 0.90182961 |
| 54 | ICK | 0.88855358 |
| 55 | LMTK2 | 0.88108830 |
| 56 | IRAK3 | 0.87266283 |
| 57 | MAPKAPK3 | 0.86473518 |
| 58 | MAP2K6 | 0.81044801 |
| 59 | FER | 0.79092006 |
| 60 | CDK6 | 0.78796791 |
| 61 | PRKACG | 0.78652657 |
| 62 | EIF2AK1 | 0.77487806 |
| 63 | MAP3K11 | 0.77151209 |
| 64 | MAPK12 | 0.73230442 |
| 65 | TIE1 | 0.72948955 |
| 66 | CAMK2G | 0.72247281 |
| 67 | GSK3A | 0.70688573 |
| 68 | DYRK1B | 0.70647842 |
| 69 | PBK | 0.70294664 |
| 70 | EPHB1 | 0.69880545 |
| 71 | PRKAA1 | 0.69531700 |
| 72 | MST4 | 0.68882917 |
| 73 | DDR2 | 0.68062319 |
| 74 | EPHA3 | 0.64979777 |
| 75 | CSK | 0.63671993 |
| 76 | PRKACA | 0.60384311 |
| 77 | TESK1 | 0.59837081 |
| 78 | SGK3 | 0.59214930 |
| 79 | PIM2 | 0.58961174 |
| 80 | GRK1 | 0.58013050 |
| 81 | RIPK1 | 0.56751837 |
| 82 | TGFBR2 | 0.56712036 |
| 83 | PTK2 | 0.56311159 |
| 84 | CAMK1D | 0.55896438 |
| 85 | IKBKE | 0.53666894 |
| 86 | NEK6 | 0.53339898 |
| 87 | KSR2 | 0.52821786 |
| 88 | EIF2AK3 | 0.51726033 |
| 89 | PDPK1 | 0.50997595 |
| 90 | PRKG1 | 0.50033786 |
| 91 | PRKCQ | 0.49658141 |
| 92 | SRC | 0.49550703 |
| 93 | EPHA4 | 0.48707629 |
| 94 | MAPK7 | 0.48615279 |
| 95 | CSNK1G1 | 0.47694024 |
| 96 | FGFR3 | 0.47040705 |
| 97 | SGK2 | 0.45635299 |
| 98 | ARAF | 0.45061003 |
| 99 | ZAP70 | 0.44797908 |
| 100 | MAP2K1 | 0.43631003 |
| 101 | IGF1R | 0.43485675 |
| 102 | NUAK1 | 0.41727838 |
| 103 | CSF1R | 0.41684607 |
| 104 | SGK223 | 0.41058486 |
| 105 | SGK494 | 0.41058486 |
| 106 | PIM1 | 0.40726989 |
| 107 | PDK3 | 0.40471644 |
| 108 | PDK4 | 0.40471644 |
| 109 | PKN1 | 0.40005021 |
| 110 | EPHB2 | 0.39546023 |
| 111 | PDGFRA | 0.39087770 |
| 112 | MUSK | 0.38975719 |
| 113 | MAP3K5 | 0.38564439 |
| 114 | CDK4 | 0.37661541 |
| 115 | TAOK2 | 0.37493744 |
| 116 | PRKCB | 0.36930430 |
| 117 | MAP3K13 | 0.36600762 |
| 118 | MAP3K6 | 0.36277718 |
| 119 | TAOK1 | 0.34869044 |
| 120 | PRKCG | 0.34846591 |
| 121 | PRKCD | 0.34710150 |
| 122 | WNK3 | 0.34406579 |
| 123 | WNK4 | 0.33484139 |
| 124 | RET | 0.32238240 |
| 125 | EGFR | 0.31041492 |
| 126 | PDK1 | 0.30594670 |
| 127 | MATK | 0.30539219 |
| 128 | MAP2K2 | 0.30487431 |
| 129 | NTRK3 | 0.30075297 |
| 130 | PRKCA | 0.29778184 |
| 131 | MTOR | 0.27187382 |
| 132 | CAMK4 | 0.26873272 |
| 133 | OXSR1 | 0.25762055 |
| 134 | CSNK1G2 | 0.23813440 |
| 135 | PIK3CA | 0.23392241 |
| 136 | MAP3K2 | 0.22974234 |
| 137 | PAK3 | 0.22803855 |
| 138 | ABL1 | 0.22296096 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.45592343 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.55938842 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.37738971 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.31673965 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.01663090 |
| 6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.70109055 |
| 7 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.69418009 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.66535954 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.65745867 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.51761252 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.51324451 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.42633801 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.27201938 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.20100320 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.14072199 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.11622205 |
| 17 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.99363833 |
| 18 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.93722706 |
| 19 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.92091206 |
| 20 | Histidine metabolism_Homo sapiens_hsa00340 | 1.91187216 |
| 21 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.89907914 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.84719362 |
| 23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.82747573 |
| 24 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.72435158 |
| 25 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.72269407 |
| 26 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.71674033 |
| 27 | Retinol metabolism_Homo sapiens_hsa00830 | 1.71294753 |
| 28 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.69345369 |
| 29 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.68128390 |
| 30 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.66821650 |
| 31 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.65098534 |
| 32 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.56781295 |
| 33 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.55283513 |
| 34 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.53405804 |
| 35 | Bile secretion_Homo sapiens_hsa04976 | 1.48945800 |
| 36 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.45582780 |
| 37 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.41294591 |
| 38 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.41068261 |
| 39 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.39794431 |
| 40 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.38274518 |
| 41 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.30329830 |
| 42 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.27987221 |
| 43 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.24469719 |
| 44 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.24049790 |
| 45 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.20070842 |
| 46 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.18857355 |
| 47 | ABC transporters_Homo sapiens_hsa02010 | 1.16194325 |
| 48 | Carbon metabolism_Homo sapiens_hsa01200 | 1.15912111 |
| 49 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.13584488 |
| 50 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.10879143 |
| 51 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.03276651 |
| 52 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.99152785 |
| 53 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.98296492 |
| 54 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.95920689 |
| 55 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.95141932 |
| 56 | Sulfur relay system_Homo sapiens_hsa04122 | 0.92956157 |
| 57 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.89945339 |
| 58 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.88123216 |
| 59 | Lysine degradation_Homo sapiens_hsa00310 | 0.82123519 |
| 60 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.74869817 |
| 61 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.73070754 |
| 62 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.72918786 |
| 63 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.68595269 |
| 64 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.59553881 |
| 65 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.54983963 |
| 66 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.52552510 |
| 67 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.51339780 |
| 68 | Metabolic pathways_Homo sapiens_hsa01100 | 0.47982451 |
| 69 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.40982591 |
| 70 | Prion diseases_Homo sapiens_hsa05020 | 0.33064676 |
| 71 | Galactose metabolism_Homo sapiens_hsa00052 | 0.28318018 |
| 72 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.28004160 |
| 73 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.27807362 |
| 74 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.23415370 |
| 75 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.22920142 |
| 76 | Pertussis_Homo sapiens_hsa05133 | 0.19805824 |
| 77 | Insulin resistance_Homo sapiens_hsa04931 | 0.19466521 |
| 78 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.18051298 |
| 79 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.14835822 |
| 80 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.13746298 |
| 81 | Other glycan degradation_Homo sapiens_hsa00511 | 0.11277268 |
| 82 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.06650199 |
| 83 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.00508767 |
| 84 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.2462832 |
| 85 | Bladder cancer_Homo sapiens_hsa05219 | -0.2380421 |
| 86 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.2334353 |
| 87 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2325596 |
| 88 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.2203463 |
| 89 | Mineral absorption_Homo sapiens_hsa04978 | -0.2006466 |
| 90 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1827806 |
| 91 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1809373 |
| 92 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1756789 |
| 93 | Hepatitis C_Homo sapiens_hsa05160 | -0.1692717 |
| 94 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1664140 |
| 95 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1647355 |
| 96 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1573830 |
| 97 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | -0.1556148 |
| 98 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1474324 |
| 99 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1335037 |
| 100 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.1324282 |
| 101 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1322254 |
| 102 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1195264 |
| 103 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1194652 |
| 104 | Amoebiasis_Homo sapiens_hsa05146 | -0.1073298 |
| 105 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0731626 |
| 106 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0434445 |
| 107 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0017451 |
| 108 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0012290 |

